US 11,767,330 B2Granted

Citrate salt, pharmaceutical compositions, and methods of making and using the same

AssigneeFoghorn Therapeutics Inc.

InventorsChong-Hui Gu, Joshua D. Waetzig

Life of this patent

Estimating the term…

Abstract

The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Claims12

Dependent claims

A citrate salt of the compound of Formula I:

Dependencies are inferred from the claim text.

Facts

Application: 17/858,875Filed 6 Jul 2022 · us provisional application
Priority: 6 Jul 2021
Published: US 2023/0064136 A12 Mar 2023
Granted: 26 Sep 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/4545
Containing further heterocyclic ring systems: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
C07D 519/00
Heterocyclic compounds containing more than one system of two or more relevant
C07D 401/04
Containing two hetero rings: directly linked by a ring-member-to-ring-member bond
C07B 2200/13
Indexing scheme relating to specific properties of organic compounds: crystalline forms, e.g. polymorphs

Family

Application63/218,776Us provisional application · filed 6 Jul 2021
US 2023/0064136 A1Pre-grant publication · published 2 Mar 2023
US 11,767,330 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results